REVBW — Revelation Biosciences, Inc.
$0.00610.00%
Last close: · regular session
Last 50 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for REVBW in the TickerWise workspace.
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 8
- Website: https://www.revbiosciences.com
Latest SEC filings for REVBW
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.